Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

Jiangsu CoWin Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	255.47	348.37	1,032	127.83	38.84
Short-Term Investments	-	90.01	-	-	-
Trading Asset Securities	417.04	545.28	402.59	233.42	303.17
Cash & Short-Term Investments	672.51	983.67	1,434	361.25	342.01
Cash Growth	-31.63%	-31.41%	297.00%	5.63%	3525.14%
Accounts Receivable	43.28	58.96	129.64	36.56	25.94
Other Receivables	2.45	1.29	0.31	-	1.1
Receivables	45.72	60.26	129.95	36.56	27.04
Inventory	45.87	32.04	52.53	32.62	24.22
Other Current Assets	69.3	8.71	10.05	7.72	4.07
Total Current Assets	833.4	1,085	1,627	438.16	397.34
Property, Plant & Equipment	381.13	394.39	246.43	159.44	30.19
Long-Term Investments	296.81	256.71	-	-	-
Goodwill	1.08	-	4.27	-	-
Other Intangible Assets	49.97	29.77	29.35	30.15	0.65
Long-Term Deferred Tax Assets	32.5	29.83	17.11	4	5.67
Long-Term Deferred Charges	20.73	24.8	11.36	13.82	9.3
Other Long-Term Assets	2.52	2.04	20.06	3.2	2.49
Total Assets	1,618	1,822	1,955	648.77	445.64
Accounts Payable	31.86	47.53	44.07	10.55	5.41
Accrued Expenses	13.99	16.69	21.69	22.12	8.86
Short-Term Debt	6.01	-	-	-	-
Current Portion of Long-Term Debt	12.12	-	-	-	-
Current Portion of Leases	-	13.65	9.05	5.67	-
Current Income Taxes Payable	0.67	-	9.56	8.21	1.97
Current Unearned Revenue	9.63	4.48	5.75	10.28	7.49
Other Current Liabilities	9.72	2.51	3.03	3.58	2.14
Total Current Liabilities	84	84.86	93.15	60.41	25.86
Long-Term Leases	9.71	19.31	31.72	34.33	-
Long-Term Unearned Revenue	30.25	30.11	29.58	5.67	5.52
Long-Term Deferred Tax Liabilities	7.75	8.32	9.1	0.06	0.24
Other Long-Term Liabilities	0.09	0.06	0.05	0.04	0.03
Total Liabilities	131.79	142.67	163.6	100.51	31.65
Common Stock	112.49	112.23	93.52	69.87	69.87
Additional Paid-In Capital	1,394	1,391	1,393	344.45	336.02
Retained Earnings	2.87	160.08	293.13	133.87	8.02
Treasury Stock	-43.66	-	-	-	-
Comprehensive Income & Other	0.33	0.3	0.27	0.07	0.09
Total Common Equity	1,466	1,664	1,780	548.26	414
Minority Interest	20.56	15.88	11.31	-	-
Shareholders' Equity	1,486	1,680	1,792	548.26	414
Total Liabilities & Equity	1,618	1,822	1,955	648.77	445.64
Total Debt	27.84	32.95	40.77	39.99	-
Net Cash (Debt)	644.67	950.72	1,393	321.25	342.01
Net Cash Growth	-32.19%	-31.77%	333.73%	-6.07%	3525.14%
Net Cash Per Share	5.78	8.47	15.00	3.81	4.89
Filing Date Shares Outstanding	111.05	112.49	112.23	83.85	83.85
Total Common Shares Outstanding	111.05	112.23	112.23	83.85	83.85
Working Capital	749.41	999.82	1,534	377.75	371.48
Book Value Per Share	13.20	14.82	15.86	6.54	4.94
Tangible Book Value	1,415	1,634	1,747	518.11	413.35
Tangible Book Value Per Share	12.74	14.56	15.56	6.18	4.93
Buildings	-	234.89	0.66	0.66	0.66
Machinery	-	188.41	133.11	75.91	40.96
Construction In Progress	-	-	110.9	64.81	0.61

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.